Quiz
Quiz: First-Line Venetoclax Plus Obinutuzumab Among Patients With CLL or SLL
04/18/2022
Current Issue
August 2025
Volume 11
Issue 4
JCP Clinical Pathways Categories
Subscribe
Journal of Clinical Pathways Newsletter